特集名 | 副甲状腺疾患とその病態 | |
---|---|---|
題名 | 副甲状腺機能亢進症におけるFGF-23-Klotho系の意義 | |
発刊年月 | 2013年 11月 | |
著者 | 椎崎 和弘 | Department of Pathology, The University of Texas Southwestern Medical Center at Dallas |
著者 | 黒尾 誠 | Department of Pathology, The University of Texas Southwestern Medical Center at Dallas |
【 要旨 】 | Klothoやfibroblast growth factor 23(FGF-23)はリンやビタミンDをおもな標的にして骨ミネラル代謝の重要な役割を担っている.この調節機構の破綻は慢性腎臓病に伴う骨ミネラル代謝異常(CKD-MBD)の発症に大きく影響している.CKD-MBDの所見の一つが二次性副甲状腺機能亢進症(SHPT)であり,この病態には腎障害に特徴的なKlothoやFGF-23の変化が関与している. KlothoはFGF receptorと複合体を形成し,FGF-23のシグナルに必須であるため,CKDの腎臓ではKlotho発現の減少が血液中のFGF-23値の上昇をもたらす.これがビタミンDを抑制し副甲状腺機能亢進症を導く.CKDの早期では,機能するネフロン数の減少をFGF-23や副甲状腺ホルモン(PTH)の上昇により代償し,リンやカルシウムの恒常性を保っている. 副甲状腺でもKlothoやFGF-23によるPTHの分泌を調節する機序が明らかになりつつあり,CKD-MBDでのPTH過剰分泌に関与していると考えられている. |
Theme | Parathyroid diseases and their pathogenesis | |
---|---|---|
Title | Role of FGF-23-Klotho in hyperparathyroidism | |
Author | Kazuhiro Shiizaki | Department of Pathology, The University of Texas Southwestern Medical Center at Dallas |
Author | Makoto Kuro-o | Department of Pathology, The University of Texas Southwestern Medical Center at Dallas |
[ Summary ] | Klotho and FGF-23 play important roles in bone and mineral metabolism including endocrine regulation of phosphate and vitamin D metabolism. CKD-induced adaptation of this endocrine axis may contribute to secondary hyperparathyroidism. Klotho is essential for FGF-23 signaling as a co-receptor of FGF receptor. Decreased Klotho expression levels in the kidneys may increase circulating FGF-23 levels. FGF-23 suppresses the activation of vitamin D, resulting in secondary hyperparathyroidism. In the early stages of CKD, increased FGF-23 and PTH levels compensate for decreased functional nephron numbers to maintain the homeostasis of phosphate and calcium. Recent studies have revealed that PTH is also regulated by Klotho and FGF-23. It is proposed that resistance of the parathyroid glands to FGF-23 may contribute to secondary hyperparathyroidism. |